BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 23518862)

  • 1. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer?
    Sahin H; Sarioglu FC; Bagci M; Karadeniz T; Uluer H; Sanci M
    Int J Gynecol Cancer; 2018 May; 28(4):666-674. PubMed ID: 29697491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
    Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?
    Cuylan ZF; Akilli H; Gungorduk K; Demirkiran F; Oz M; Salman MC; Sozen H; Celik H; Gokcu M; Bese T; Meydanli MM; Ozgul N; Topuz S; Kuscu E; Kuru O; Gokmen S; Gultekin M; Ayhan A
    J Obstet Gynaecol Res; 2021 Mar; 47(3):1134-1144. PubMed ID: 33426779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.
    Yan B; Liang X; Zhao T; Niu C; Ding C; Liu W
    Eur Radiol; 2019 Feb; 29(2):838-848. PubMed ID: 30039225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
    Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.